drugset

drugset / Trial / NCT04124861

Withdraw Drug in Stable IgG4-Related Disease

NCT04124861 ↗

Unknown 138 enrolled Peking Union Medical College Hospital Chinese PLA General Hospital · collab Peking University People's Hospital · collab Shengjing Hospital · collab The People's Hospital of Hebei Province · collab Tongji Hospital · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation and prediction of relapse risk after glucocorticoid or immunosuppressant withdrawal in patients with stable IgG4 related disease: a prospective cohort study from china.

Timeline

Start: 2020-06-23
Primary completion: 2022-12-30
Completion: 2023-06-30

Publications

Peng L, Nie Y, Zhou J, Wu L, Chen X, Wang F, Li J, Peng Y, Lu H, Zhao L, Li M, Zhao Y, Zeng X, Fei Y, Zhang W. Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial. Ann Rheum Dis. 2024 Apr 11;83(5):651-660. doi: 10.1136/ard-2023-224487.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azathioprine	Small molecule	—	—
Subject	Leflunomide	Small molecule	—	—
Subject	Methotrexate	Small molecule	—	—
Subject	Mycophenolate mate	Unknown	—	—
Subject	Prednisone	Other / unclassified	—	—

Indications